Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency

Luis Ignacio González-Granado1, Andrea Martín-Nalda2, Laia Alsina3

  • 1Unidad de Inmunodeficiencias, Pediatría, Instituto de Investigación Hospital 12 de Octubre, Facultad de Medicina, Universidad Complutense, Madrid, Spain.

Anales De Pediatria
|May 31, 2022
PubMed

Insights

Children with primary immunodeficiencies (PIDs) admitted for severe respiratory syncytial virus (RSV) infection were most often diagnosed with combined immunodeficiency (CID) or CID with associated features (CIDwASF). These specific PIDs require focused RSV prevention strategies.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Severe acute respiratory infections (SARI) pose a significant risk to children with primary immunodeficiencies (PIDs).
  • Respiratory syncytial virus (RSV) is a common pathogen causing SARI in this vulnerable population.

Purpose of the Study:

  • To determine the incidence and severity of RSV-associated hospital admissions in children with PIDs.
  • To identify specific types of PIDs at higher risk for severe RSV infections.

Main Methods:

  • A nationwide, multicenter, cross-sectional study was conducted between 2011 and 2017 in Spain.
  • Included were children with PIDs admitted for RSV-associated acute respiratory infections (RSV-ARI) across 15 hospitals.

Main Results:

  • Out of 439 children with PIDs, 13 (3%) were hospitalized for RSV-ARI.
  • Combined immunodeficiency (CID) and CID with associated or syndromic features (CIDwASF) were the most frequent PID types associated with RSV-ARI hospitalization.
  • Complications occurred in 39% of admitted patients, with 31% requiring pediatric intensive care unit admission; no RSV-related deaths were reported.

Conclusions:

  • Children with CID and CIDwASF are at a higher risk for severe RSV infections requiring hospitalization.
  • Targeted preventive measures against RSV are crucial for these specific PID subgroups.
  • Further research is warranted to validate these findings and inform clinical practice.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
217
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
463
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
391
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
958